Stocks · News reference

Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue

Aug 6, 2026, 12:33 PMVandana Singh

Sonoma Pharmaceuticals reported record Q1 revenue, narrow loss, doubled U.S. sales and achieved positive adjusted EBITDA for the first time.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 6, 2026, 12:33 PM
Checked: Aug 6, 2026, 12:33 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 6, 2026, 1:03 PMBenzinga Newsdesk
Sonoma Pharmaceuticals shares are trading higher after the company reported a year-over-year increase in Q1 financial results.
Read original at benzinga
SNOA
BenzingaAug 6, 2026, 12:34 PMBenzinga Newsdesk
Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.09) per share. This is a 88.16 percent increase over losses of $(0.76) per share from the same period last year. The company reported $6.406 million
Read original at benzinga
SNOA
BenzingaJun 30, 2026, 1:03 PMBenzinga Newsdesk
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance For Its Microdacyn Wound Irrigation Solution
Read original at benzinga
SNOA